Vaccinia Virus DD-CDSR

A highly tumor-selective vaccinia virus (vv) with an engineered double deletion (DD) of the thymidine kinase (tk) and vaccinia growth factor genes and additions of both a cytosine deaminase (CD) gene and a somatostatin receptor (SR) gene with potential oncolytic viral activity. The tk and vaccinia growth factor gene deletions in intratumorally administered vaccinia virus (vvDD-CDSR) help to restrict its replication and cytolytic activity to tumor cells with large nucleotide pools and tumor cells with activation of the EGFR-Ras pathway. Addition of the CD gene to the viral genome allows control of oncolytic viral infection through the administration of the prodrug 5-fluorocytosine (5-FC), converted by CD to the antimetabolite 5-fluorouracil (5-FU) in cells infected with this agent. Addition of the SR gene allows anatomical localization of vaccinia virus (vvDD-CDSR) through the use of octreotide scintigraphy. (NCI Thesaurus)

YOU MAY ALSO LIKE

Vaccinia Virus

DNA viruses used in several biotechnology applications, including expression vector systems.

Vaccinia Vaccine

A class of antineoplastic vaccines containing the vaccinia virus, originally used for immunization against smallpox, as a viral vector and immunogenic…

vaccinia CEA vaccine

A vaccine made by putting the gene for carcinoembryonic antigen (CEA) into the vaccinia virus. The vaccinia virus is related to the…

Vaccine-Sensitized Draining Lymph Node Cells

Cells isolated from lymph nodes from patients, and activated in vitro to generate tumor-specific effector T cells. Lymph nodes in the…

Vaccine therapy

A type of treatment that uses a substance or group of substances to stimulate the immune system to destroy a tumor or…

Vaccine Research

Research focusing on any aspect of vaccine research, development, testing, etc.